Risankizumab 00074-5025-99
- Manufacturer
- Abbvie Inc.
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- April 4, 2025
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Risankizumab | 600 mg/10mL |
Selected Package
00074-5025-99Selected4 TRAY in 1 CASE (0074-5025-99) / 90 VIAL in 1 TRAY / 1 VIAL, SINGLE-DOSE in 1 VIAL / 10 mL in 1 VIAL, SINGLE-DOSE